Both in Pharmaceuticals
Aquestive Therapeutics vs CytomX Therapeutics
Over the past year AQST returned −38.9% and CTMX returned −42.0%; their daily moves had a correlation of 0.15.
AQST −38.9% CTMX −42.0%Growth of $1, one year, split-adjusted
| Metric | AQST | CTMX |
|---|---|---|
| Price | $3.97 | $2.28 |
| Market cap | $497.7M | $496.8M |
| Today | +2.19% | +4.59% |
| 1 month | −14.0% | −10.9% |
| 6 months | −6.3% | −44.8% |
| Year to date | −38.6% | −46.5% |
| 1 year | −38.9% | −42.0% |
| Revenue growth (YoY) | +38.1% | −92.4% |
| Gross margin | 70.9% | 100.0% |
| Net margin | −165.5% | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | 9.2× | 27.1× |
| Net cash | $47.8M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 54.2% | 68.4% |
| Short % of float | 25.6% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).